The EUROCARE study: Strengths, limitations and perspectives of population-based, comparative survival studies

Annals of Oncology

Volumn 14, Issue SUPPL.5, 2003, Pages

  Berrino, F ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; COMPARATIVE STUDY; EDITORIAL; FOLLOW UP; HEALTH PROGRAM; HUMAN; METHODOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TUMOR CLASSIFICATION; EUROPE; MORTALITY; NEOPLASM; REGISTER; STATISTICS; SURVIVAL; SURVIVAL RATE;

EUROPE; FOLLOW-UP STUDIES; HUMANS; NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 5444274174     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdg750     Document Type: Editorial

References (25)

1. Cutler SJ (ed.): International Symposium on End Results of Cancer Therapy. NCI Monograph 15. Bethesda, MD: National Cancer Institute 1964.
2. Berrino F, Sant M, Verdecchia A et al. (eds): Survival of Cancer Patients in Europe: the EUROCARE Study. IARC Scientific Publications No. 132. Lyon, France: IARC 1995.
3. Berrino F, Capocaccia R, Estève J et al. (eds): Survival of Cancer Patients in Europe: the EUROCARE-2 Study. IARC Scientific Publications No. 151. Lyon, France: IARC 1999.
4. Coebergh JWW, Sant M, Berrino F, Verdecchia A. Survival of adult cancer patients in Europe diagnosed from 1978-89: the EUROCARE II study. Eur J Cancer 1998; 34: 2137-2278.
5. Capocaccia R, Gatta G, Magnani C et al. (eds): Childhood Cancer Survival in Europe 1978-1992: the EUROCARE Study. Eur J Cancer 2001; 37: 671-816.
6. Irwig L, Armstrong B. EUROCARE-2: relevance for assessment of quality cancer services? Lancet 2000; 355: 427-428.
7. Peto R, Boreham J, Clarke M et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 60-69 years. Lancet 2000; 355: 1822.
8. Berrino F, Gatta G, Sant M, Capocaccia R. The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses. Eur J Cancer 2001; 37: 673-677.
9. Sant M. Differences in stage and therapy for breast cancer across Europe. The EUROCARE Working Group. Int J Cancer 2001; 93: 894-901.
10. Sant M, Allemani C, Capocaccia R et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003; 106: 416-422.
11. Gatta G, Capocaccia R, Sant M et al. Understanding variations in colorectal cancer survival in Europe: a EUROCARE high-resolution study. Gut 2000; 47: 533-538.
12. Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumori 1997; 83: 9-16.
13. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comp Programs Biomed 1985; 19: 197-207.
14. Bullard J, Coleman MP, Robinson D et al. Completeness of cancer registration: a new method for routine use. Br J Cancer 2000; 82: 1111-1116.
15. Robinson D, Bell J, Møller H. Comparing survival rates between different registries can be difficult. Br Med J 2000; 321: 1227-1128.
16. Stotter A, Bright N, Silcocks P, Botha JL. Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database. Br Med J 2000; 321: 214.
17. Brewster DH, Crichton J, Harvey JC, Dawson G. Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992. Public Health 1997; 5: 339-343.
18. Sant M, Gatta G. The EUROCARE database. Survival of cancer patients in Europe: the EUROCARE study. In Berrino F, Sant M, Verdecchia A et al. (eds): Survival of Cancer Patients in Europe: the EUROCARE Study. IARC Scientific Publications No. 132. Lyon, France: IARC 1995; 15-31.
19. Moreno C, Ardanaz E, Pérez De Rada ME, Ezponda C. Validez de los datos de supervivencia del registro de càncer de Navarra. Seguimiento pasivo vs activo. XXVIII Reunion del Groupo para la Epidemiologia y registros de càncer en paises de lengua latina. La Habana, Cuba, 27-30 May 2003.
20. Garau I, Obrador A, Franch P, Mulet M. Dificultad, costo y calitad de los datos del registro de Mallorca para un estudio de alta resoluciòn. XXVIII Reunion del Groupo para la Epidemiologia y registros de càncer en paises de lengua latina. La Habana, Cuba, 27-30 May 2003.
21. Berrino F, Estève J, Coleman MP. Basic issues in estimating and comparing the survival of cancer patients. In Berrino F, Sant M, Verdecchia A et al. (eds): Survival of Cancer Patients in Europe: the EUROCARE Study. IARC Scientific Publications No. 132. Lyon, France: IARC 1995; 1-14.
22. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. The EUROCARE Working Group. Eur J Cancer 1998; 34: 2154-2161.
23. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002; 360: 1131-1135.
24. Brenner H, Soderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland. Int J Epidemiol 2002; 31: 456-462.
25. Verdecchia A, De Angelis R, Capocaccia R et al. The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998; 77: 322-329.